# Oncology Today with Dr Neil Love: Novel Immunotherapeutic Strategies in Melanoma

Page: https://stenobird.com/podcast/dermatologic-oncology-update-450819/oncology-today-with-dr-neil-love-novel-immunotherapeutic-strategies-in-melanoma
Text version: https://stenobird.com/podcast/dermatologic-oncology-update-450819/oncology-today-with-dr-neil-love-novel-immunotherapeutic-strategies-in-melanoma.md
Podcast: [Dermatologic Oncology Update](https://stenobird.com/podcast/dermatologic-oncology-update-450819)
Published: 2022-12-13T12:17:00+00:00
Episode link: https://dermatologic.researchtopractice.com/episode/oncology-today-with-dr-neil-love-novel-immunotherapeutic-strategies-in-melanoma
Audio file: https://dts.podtrac.com/redirect.mp3/podcasts.captivate.fm/media/399154dc-4e89-4f58-81d2-71189696e8dc/oncologytodaynovelstrategiesmelanoma22-converted.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/dermatologic-oncology-update-450819/episodes/oncology-today-with-dr-neil-love-novel-immunotherapeutic-strategies-in-melanoma
Duration seconds: 2997

## Resource

Featuring a discussion on novel immunotherapies and combination treatments for patients with metastatic melanoma with Dr Omid Hamid, moderated by Dr Neil Love.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/dermatologic-oncology-update-450819/episodes/oncology-today-with-dr-neil-love-novel-immunotherapeutic-strategies-in-melanoma/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/dermatologic-oncology-update-450819/oncology-today-with-dr-neil-love-novel-immunotherapeutic-strategies-in-melanoma.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.